According to filings with the U.S. Securities and Exchange Commission, Beaconcure is raising $14,000,000.00 in new funding. Sources indicate that as part of senior management President, Yoran Bar played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Beaconcure
With Beaconcure, pharmaceutical companies and CROs can validate clinical trial data for regulatory approval while cutting submission timelines in half! By using ‘Verify’ by Beaconcure, any data inconsistency will be detected automatically during the QC process, reducing handling time and eliminating the possibility of an error-filled submission. In collaboration with Pfizer, Beaconcure algorithms are designed and trained to support all types of therapeutic areas and study sizes. With our technology, customers can introduce new treatments earlier to patients, while maintaining IP protection deadlines, accelerating the pipeline so that they can make early revenue and be first to market.

To learn more about Beaconcure, visit http://beaconcure.com/

Contact:
Yoran Bar, President
617-345-3627
https://www.linkedin.com/in/yoranbar/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.